THE ROLE OF THE BUN-TO-ALBUMIN RATIO IN PREDICTING CONTRAST-INDUCED NEPHROPATHY AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH NSTEMI
- 15 June 2026
- journal article
- Published by Bozok Tip Dergisi in Bozok Tıp Dergisi
- Vol. 16 (2) , 336-345
Abstract
Objective: Contrast-induced nephropathy (CIN) remains a common complication after percutaneous coronary intervention (PCI) in patients with non-ST-segment elevation myocardial infarction (NSTEMI). The BUN-to-albumin ratio (BAR) has recently emerged as a composite biomarker reflecting inflammation, renal function, and nutritional status. To evaluate the predictive value of BAR for CIN in NSTEMI patients undergoing PCI.Material and Methods: This retrospective study included 1,540 NSTEMI patients treated with PCI between 2020 and 2024. Patients were divided into CIN (+) and CIN (-) groups. Clinical, laboratory, and procedural variables were analyzed. Multivariate logistic regression and receiver operating characteristic (ROC) curve analyses were performed to identify independent predictors and assess discriminative performance.Results: CIN developed in 204 patients (13.2%). BAR was significantly higher in the CIN group (5.2±1.5 vs. 4.0±1.2, p<0.001). In multivariate analysis, BAR emerged as an independent predictor of CIN (OR: 1.943, 95% CI: 1.703-2.217, p<0.001). ROC analysis showed that BAR had the highest discriminative ability (AUC: 0.726), outperforming NLR (AUC: 0.654) and the Mehran score (AUC: 0.599). A cut-off value of 4.5 yielded 69.1% sensitivity and 63.8% specificity.Conclusion: BAR is a simple, inexpensive, and effective predictor of CIN in NSTEMI patients undergoing PCI and may serve as a practical tool for risk stratification in clinical practice.Keywords
Funding Information
- No funding was received for this study
This publication has 39 references indexed in Scilit:
- Inflammatory Markers and Contrast‐Induced Nephropathy Risk: A Meta‐Analysis of NLR and PLR in ACS Patients Undergoing Percutaneous Coronary InterventionCatheterization and Cardiovascular Interventions, 2025
- Blood–urea–nitrogen-to-serum–albumin ratio in predicting the value of patients with contrast-induced nephropathy for coronary heart diseaseInternational Urology and Nephrology, 2024
- Contrast-Induced Nephropathy: An OverviewDr. Sulaiman Al Habib Medical Journal, 2023
- Blood Urea Nitrogen to Serum Albumin Ratio as a New Prognostic Indicator in Critical Patients with Chronic Heart FailureESC Heart Failure, 2022
- Serum albumin and cardiovascular disease: State-of-the-art reviewAnnales de Cardiologie et d'Angéiologie, 2020
- Elevated urea-to-creatinine ratio provides a biochemical signature of muscle catabolism and persistent critical illness after major traumaIntensive Care Medicine, 2019
- Relation of Contrast-Induced Nephropathy to Long-Term Mortality After Percutaneous Coronary InterventionThe American Journal of Cardiology, 2014
- A simple preprocedural score for risk of contrast‐induced acute kidney injury after percutaneous coronary interventionCatheterization and Cardiovascular Interventions, 2013
- Impact of anemia on contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary interventionsInternational Urology and Nephrology, 2012
- Emergence of Blood Urea Nitrogen as a Biomarker of Neurohormonal Activation in Heart FailureThe American Journal of Cardiology, 2010